Drug Profile


Alternative Names: Dexketoprofen trometamol/dicycloverine; Dexketoprofen/dicyclomine; Dicycloverine/dexketoprofen trometamol; DXD; Infen Spas

Latest Information Update: 20 Apr 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Emcure Pharmaceuticals
  • Class Antispasmodics; Nonsteroidal anti-inflammatories; Phenylpropionates; Propylene glycols; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; Muscarinic receptor antagonists; S100 protein antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Acute pain

Most Recent Events

  • 20 Apr 2016 Launched for Acute pain in India (IM) before April 2016
  • 22 Sep 2010 Phase-III clinical trials in Acute pain in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top